about
Novel immunotherapies for hematologic malignanciesSilencing of human phosphatidylethanolamine-binding protein 4 enhances rituximab-induced death and chemosensitization in B-cell lymphomaCombination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma.Structural complementation of the catalytic domain of pseudomonas exotoxin AFavorable outcome in non-Hodgkin lymphoma of the maxillary sinus treated with R-CHOP.Preclinical development of a bispecific antibody that safely and effectively targets CD19 and CD47 for the treatment of B cell lymphoma and leukemia.
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Rituximab in the treatment of non-Hodgkin's lymphoma
@en
type
label
Rituximab in the treatment of non-Hodgkin's lymphoma
@en
prefLabel
Rituximab in the treatment of non-Hodgkin's lymphoma
@en
P2860
P356
P1476
Rituximab in the treatment of non-Hodgkin's lymphoma
@en
P2093
Beate Hauptrock
Georg Hess
P2860
P304
P356
10.2147/BTT.S3235
P577
2008-12-01T00:00:00Z